Singer Capital Markets is delighted to have been appointed as Nominated Adviser and Joint Broker to Arecor Therapeutics plc with immediate effect.
About Arecor Therapeutics plc
Arecor Therapeutics plc is a globally focused biopharmaceutical company that is transforming patient care by bringing innovative medicines to market.
Through the enhancement of existing medicines using the Company’s Arestat™ technology, Arecor Therapeutics are developing a broad portfolio of therapies as part of their proprietary pipeline and through partnerships with leading pharmaceutical and biotech companies. The Company’s treatments for people living with chronic disease are designed to simplify patient care and improve medication adherence.
Ticker: AREC
Market Cap: £27.9m
Website: Click here
*As at 09/01/2024
Let’s Talk
If you’re looking for more information about any of our services, or if you can’t find what you’re looking for directly on our site, please do not hesitate to contact us.
